Published in Nephrol Dial Transplant on November 01, 1999
Resistance to erythropoietin-stimulating agents: etiology, evaluation, and therapeutic considerations. Pediatr Nephrol (2011) 0.75
Why and how to monitor bacterial contamination of dialysate? Nephrol Dial Transplant (2000) 0.90
[Clinical and analytical changes in hemodialysis without acetate]. Nefrologia (2007) 0.81
Transfusion-induced anergy: skin test as an index for pretransplant transfusions. Proc Eur Dial Transplant Assoc (1983) 0.78
Effects of L-carnitine on erythrocyte acyl-CoA, free CoA, and glycerophospholipid acyltransferase in uremia. Am J Clin Nutr (1998) 0.77
[Is the index of response to erythropoietin (IRE) a good marker of adequate dialysis?]. Nefrologia (2001) 0.76
L-Carnitine in dialysis, more than a commercial affair. Nephrol Dial Transplant (2000) 0.75
[The essential role of water treatment system (WTS) in the qualify of water for hemodialysis]. Nefrologia (2008) 0.75
Increasing of renal replacement therapy (RRT) in diabetic patients in Madrid. Nephrol Dial Transplant (1999) 0.75
[Prospective study of the effect of propanolol on Ca-P metabolism in chronic renal insufficiency]. Rev Clin Esp (1982) 0.75
Human immunodeficiency virus infection in patients on maintenance dialysis. Nephron (1996) 0.75
[Role of the Glomerulonephritis Registry of the Spanish Society of Nephrology: past, present and future]. Nefrologia (2000) 0.75
[Segmental renal hypoplasia and arterial hypertension. Study of 8 cases]. Actas Urol Esp (1979) 0.75
r-HuEPO resistance and dialysate chloramine contamination in patients on hemodialysis. Nephron (2000) 0.75
[Association of papulous mucinosis and systemic lupus erythematosus with membranous glomerulonephritis]. Rev Clin Esp (1980) 0.75
[Acute nephrotoxic renal insufficiency]. Med Clin (Barc) (1987) 0.75
How to prescribe optimal haemodialysis. Nephrol Dial Transplant (1996) 0.75
[Diabetes mellitus as cause of terminal renal failure. An epidemic of the 21st Century?]. Nefrologia (2001) 0.75
[Anemia management in haemodialysis. EuCliD database in Spain]. Nefrologia (2002) 0.75
Efficiency of once-weekly subcutaneous administration of recombinant human erythropoietin versus three times a week administration in hemodialysis patients. Nephron (1996) 0.75
[Papulous mucinosis or scleromyxedema. Etiopathogenic, diagnostic and therapeutic aspects]. Rev Clin Esp (1980) 0.75
[Acetate-free on-line PHF: how to improve hyperacetatemia and haemodynamic tolerance]. Nefrologia (2009) 0.75